A lot of people get frustrated with peptide companies in general, with return policies and package protection. This story goes both ways. Look at this fake AI-generated image somebody tried to send in to get a refund on their order. This is clearly fake, but some good fakes are out there. People like this are honestly the worst, and if you ever attempt to scam a peptide company like this, word gets out to other owners as well. It sucks that a small group of people ruins it for everyone.

There's been some fear mongering circulating because a creator made a video saying you shouldn't refrigerate Tesamorelin. Here's the thing—he was talking about Egrifta, the pharmaceutical version. Not the same situation. Huge shout out to @Barry Freeman for digging into this further. Let me break down why RUO Tesa is fundamentally different and why you should absolutely still refrigerate it like every other lyophilized peptide. Same Active Ingredient ≠ Same Product Yes, Egrifta and RUO Tesamorelin share the same active ingredient. But Egrifta is an FDA-approved product held to a much higher standard for purity, excipients, endotoxins, and stability. This is exactly why context matters—"gray market" products, while chemically similar, a lot of the times don't have the same stabilization ingredients. RUO tesamorelin is not manufactured under drug GMP the way an FDA-approved product is. Even when a vendor provides a COA, it may not cover the same parameters, not to the same standard, and sometimes not even for the final vial you receive. (Common problem: testing a bulk batch, then aliquoting later.) Why Egrifta Doesn't Need Refrigeration EGRIFTA WR isn't just peptide in BAC water. It's a deliberately engineered formulation: - Hydroxypropyl-β-cyclodextrin → stabilizes peptide conformation - pH tightly buffered (≈4.5–7.4) This formulation was stress-tested during FDA stability studies at room temperature for 7 days. Refrigeration wasn't required to preserve potency within that validated window. The product was specifically engineered so refrigeration adds no benefit—and may actually introduce instability through temperature cycling, condensation, or crystallization effects. The Bottom Line Your RUO Tesamorelin doesn't have that sophisticated stabilization system. It's a lyophilized peptide like any other, and it should be treated like one. Refrigerate it. Don't let a video about a completely different product change how you handle your research materials. Context matters.

For everyone who placed orders this past week — the winter storm hitting multiple states right now is causing major delays with UPS and FedEx. The peptide companies can't control this. I know they're all getting flooded with emails asking about tracking updates, but there's genuinely nothing they can do until the carriers get moving again. Please be patient and considerate with their support teams. They want your package to arrive just as much as you do. 🚨 Scam Reminder No legitimate peptide company will EVER reach out to you via Telegram or DM. Period. All communication should happen through email or directly on their website. If someone slides into your DMs claiming to be a vendor, it's a scam. Always make your purchases through peptideprice.store to make sure you're going to a vetted source. Stay safe out there ✌️

Well, add Amazon to the list. Just got this email today. My Amazon Associates account has been closed, effective immediately. No warning. No specific reason. Just "not in compliance with the Operating Agreement." The kicker? The only things on my storefront were research supplies and travel cases. We're talking: - Bacteriostatic water - Syringes - Alcohol swabs - Travel cases - Storage supplies That's it. Products that Amazon themselves sell. Products that are completely legal. Products that thousands of other people recommend without issue. But apparently recommending them in the context of peptide research crosses some invisible line. Thank god I moved peptideprice.store to a server overseas because I guarantee it would have been taken down again. Wild

For research and educational purposes only. Not medical advice. I get this question all the time: "Can I research tirzepatide one week and retatrutide the next? I want the food noise suppression from tirz but also the glucagon benefits from reta." I get it. The logic sounds reasonable on paper. But here's why this approach almost always backfires. First, Let's Talk Half-Lives This is where most people get tripped up. - Tirzepatide half-life: ~5 days - Retatrutide half-life: ~6 days What does half-life mean? It's how long it takes for half the peptide to leave your system. Here's the part people miss: it takes 4-5 half-lives to reach steady state. That's when the peptide fully saturates and you experience its real effects. For tirzepatide, that's about 20-25 days. For retatrutide, that's about 24-30 days. This is exactly why titration protocols say to wait 4 weeks before adjusting dose. You need that time to know what's actually happening. When you alternate weekly, neither peptide ever reaches steady state. You're perpetually in limbo. Here's What Happens When You Alternate Let's walk through it: Week 1: You inject tirzepatide. Your body starts building toward saturation. You're nowhere close yet. Week 2: You inject retatrutide. But wait, tirzepatide has a 5-day half-life, so about half of it is still in your system. Now retatrutide starts building while tirz is declining. Week 3: Back to tirzepatide. Retatrutide is still hanging around (6-day half-life, remember). Now you're adding more tirz on top of what never fully cleared. Week 4+: You've got a messy soup of both peptides at random, fluctuating levels. Neither one is stable. Neither one is optimized. Your system never gets a chance to stabilize. Problem #1: Your Hunger Signals Become Unpredictable This is the most frustrating part for researchers. One week appetite suppression feels strong. Next week it partially fades as levels shift. Then it comes back differently. You can't establish consistent eating patterns because you never know how you're going to feel.